Recruiting × Hematologic Neoplasms × Plasma cell × Clear all MonumenTAL-1
Phase 2 Recruiting
510 enrolled 1 FDA
Discontinuation Study
Phase NA Recruiting
70 enrolled
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Phase 1 Recruiting
20 enrolled
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Phase NA Recruiting
400 enrolled
DISCOVERY
Phase NA Recruiting
500 enrolled
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/2 Recruiting
250 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Recruiting
100 enrolled
HEME Home Transfusion Program
Phase NA Recruiting
700 enrolled
Cardio CAR-T
Recruiting
60 enrolled
MMYLIFE
Recruiting
190 enrolled
Mosaic
Phase NA Recruiting
356 enrolled
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Phase NA Recruiting
60 enrolled
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Phase 1/2 Recruiting
128 enrolled
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
Phase NA Recruiting
100 enrolled
SANGUINE
Recruiting
3,000 enrolled
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
Phase 1 Recruiting
60 enrolled
PALS_CT
Phase NA Recruiting
152 enrolled
PEACE
Phase NA Recruiting
90 enrolled
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Phase 1 Recruiting
100 enrolled
RATIONALISE
Phase 2/3 Recruiting
300 enrolled
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
Phase NA Recruiting
68 enrolled
ENROL
Recruiting
37,090 enrolled
HLA
Phase 2 Recruiting
114 enrolled
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
Phase 1 Recruiting
10 enrolled
HemoDiag
Recruiting
500 enrolled